University of North Carolina at Chapel Hill
Grantee website Chapel Hill, North Carolina, United StatesPurpose
to identify potent escape-resistant human monoclonal antibodies that prevent COVID-19 for use in low and middle-income countries
Grantee
Division
Global Health
Date
APRIL 2021
Region served
GLOBAL
Committed amount
$447,373
Grant topic
Discovery and Translational Sciences
Duration (months)
51
Grantee location
Chapel Hill, North Carolina, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.